DBV Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DBVT and buy or sell other stocks, ETFs, and their options commission-free!

About DBVT

DBV Technologies SA is a clinical-stage biopharmaceutical company, which engages in the research and development of epicutaneous immunotherapy products. The firm focuses on the development of Viaskin, an electrostatic patch, which may offer a convenient, self-administered, and non-invasive immunotherapy to patients. 

CEO
Daniel Tassé
CEODaniel Tassé
Employees
109
Employees109
Headquarters
Chatillon, Hauts-de-France
HeadquartersChatillon, Hauts-de-France
Founded
2002
Founded2002
Employees
109
Employees109

DBVT Key Statistics

Market cap
452.62M
Market cap452.62M
Price-Earnings ratio
-2.79
Price-Earnings ratio-2.79
Dividend yield
—
Dividend yield—
Average volume
196.67K
Average volume196.67K
High today
$15.66
High today$15.66
Low today
$15.21
Low today$15.21
Open price
$15.43
Open price$15.43
Volume
203.60K
Volume203.60K
52 Week high
$16.98
52 Week high$16.98
52 Week low
$2.20
52 Week low$2.20

Analyst ratings

83%

of 6 ratings
Buy
83.3%
Hold
0%
Sell
16.7%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.